Medical News

RSS

Studies: Trauma centers would be strained by patient load in terrorist attack

The Wall Street Journal reports that, according to experts and private studies, "[m]any urban hospitals lack sufficient medical staff, beds, equipment and 'surge' plans to provide optimal care for potentially hundreds or thousands of patients from a large bombing, emergency and trauma doctors say."

12 May 2010

MIT featured in U.S. Equity News

Micro Identification Technologies, Inc., a leader in rapid bacterial identification, today announces it was recently featured in an editorial published by U.S. Equity News that covers the history of bacteria, its life threatening effects, and publicly traded companies leading the fight against harmful bacteria.

12 May 2010

Neurimmune Therapeutics honored with ZKB TECHNOPARK Pioneer Award

The ZKB TECHNOPARK® Pioneer Award, which has been sponsored by the Zürcher Kantonalbank since 2000, was presented for the 20th time at TECHNOPARK® Zurich. The award is given for technological innovations which - thanks to pioneering entrepreneurial achievements - are about to be launched on the market. This year's award winner is Neurimmune Therapeutics AG, represented by Dr. Jan Grimm, Professor Christoph Hock, Professor Roger Nitsch and Dr. Michael Salzmann.

12 May 2010

Vetter signs preferred partnership agreement with Sentry BioPharma Services

Vetter, a leading provider of aseptic pre-filled drug-delivery systems, and Sentry BioPharma Services, a provider of supply chain management and clinical packaging services, today announced that they have signed a preferred partnership agreement.

12 May 2010

Patients who participate in physical therapist-led exercise achieve higher functional mobility: Report

Patients who are critically ill and participate in mild exercise programs led by physical therapists achieve higher functional mobility and spend fewer days in intensive care units and hospitals than those who receive less exercise, according to a report published in the April issue of the Archives of Physical Medicine and Rehabilitation.

12 May 2010

Brookdale Senior Living announces sale of 10,000,000 shares by Fortress Investment Group affiliates

Brookdale Senior Living Inc. announced today the sale of an aggregate of 10,000,000 shares of its common stock by certain affiliates of Fortress Investment Group LLC. The Company will not sell any shares in the offering and will not receive any of the proceeds from the offering. Subject to customary conditions, the offering is expected to close on May 17, 2010.

12 May 2010

R.I. overhauls Medicaid payments for elderly, disabled; Medicaid delays reported in Kansas

Rhode Island received a waiver from the Bush administration to revamp its Medicaid program for the elderly and disabled, despite concerns from "community health activists [who] feared that it would push some of the neediest onto waiting lists or worse — throw some poor people off the Medicaid rolls altogether.

12 May 2010

Japanese MHLW approves St. Jude Medical's AnalyST ICD with ST Monitoring device

St. Jude Medical, Inc., a global medical device company, today announced regulatory approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) of its AnalyST™ implantable cardioverter defibrillator (ICD) with ST Monitoring, a revolutionary device that not only provides life-saving therapy for dangerously fast heart rhythms, but also continuously monitors electrical changes (called ST segments) to help physicians monitor for cardiac problems.

12 May 2010

Angiogenesis inhibitors safe for cancer patients despite hypertension risk: Panel

A new class of cancer drugs can be used effectively while minimizing hypertensive side effects if patients' blood pressure is closely monitored and controlled, a clinical panel has determined.

12 May 2010

Tensions escalate between Obama administration, health insurers

CQ HealthBeat: "WellPoint CEO Angela Braly is protesting comments President Obama made about how a health insurance company treated women diagnosed with breast cancer. [Her] letter marks another battle in the ongoing clash between the administration and the insurance companies — most prominently WellPoint — that hasn't lessened after enactment of the new health care law" (Norman, 5/10).

12 May 2010

St. Jude Medical launches Promote Quadra CRT-D in Europe

St. Jude Medical, Inc., a global medical device company, today announced the European launch of its Promote Quadra™ cardiac resynchronization therapy defibrillator (CRT-D). The Promote Quadra CRT-D is the industry's first quadripolar pacing system, which offers physicians the ability to more effectively and efficiently manage the ever-changing pacing needs of patients with heart failure.

12 May 2010

CHD mortality rate in Ontario decreased by 35%: Study

From 1994 to 2005 in Ontario, Canada, there was a 35 percent decrease in the rate of deaths from coronary heart disease, with about half of this reduction associated with improvements in traditional CHD risk factors such as total cholesterol levels and systolic blood pressure, according to a study in the May 12 issue of JAMA.

12 May 2010

Oncos Therapeutics completes € 4 million investment from HealthCap

Oncos Therapeutics, a biotech company developing new cancer therapeutics based on its next generation oncolytic viruses, completed a € 4 million ($ 5.5 million) investment from HealthCap. With committed capital exceeding € 800 million, HealthCap is one of the largest specialized providers of venture capital within life sciences in Europe.

12 May 2010

Sanofi-aventis commences multinational Phase IIIb PALLAS trial of Multaq in permanent AF patients

Sanofi-aventis announced today the initiation of a multinational, randomized double-blind Phase IIIb trial, PALLAS, to assess the potential clinical benefit of Multaq(R) (dronedarone) in over 10, 000 patients with permanent atrial fibrillation (AF) to reduce major adverse cardiovascular events. The announcement was made during Heart Rhythm 2010, the Heart Rhythm Society's 31st Annual Scientific Sessions.

12 May 2010

$Study shows high-dose vitamin D therapy may increase risk of fracture in elderly women$

Study shows high-dose vitamin D therapy may increase risk of fracture in elderly women

Women age 70 years or older who received a single annual high dose of vitamin D had a higher rate of falls and fractures compared to women who received placebo, according to a study in the May 12 issue of JAMA.

12 May 2010

Gilead Sciences board authorizes $5 billion common stock repurchase program

Gilead Sciences, Inc. today announced that the company's Board of Directors has authorized the repurchase of up to $5 billion of the company's common stock through May 2013.

12 May 2010

NY public hospital system plans to lay off about 500 workers and other state news

The Wall Street Journal: "New York City's Health & Hospitals Corp., the nation's largest public hospital system, plans to stanch a $1.2 billion budget gap in the next year's budget by laying off about 500 workers and ending contracts with 'a significant number' of physicians, its president said.

12 May 2010

LifeCodexx AG develops test using Next Generation Sequencing technologies for prenatal diagnostics

LifeCodexx AG has started operational research and development work on clinically validated diagnostic tests by using Next Generation Sequencing technologies. The work currently focuses on the field of prenatal diagnostics.

12 May 2010

FDA Dermatology and Ophthalmology Drugs Advisory Committee to review Lux Biosciences’ Luveniq NDA

Lux Biosciences, Inc. today announced that the Dermatology and Ophthalmology Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is scheduled to review its New Drug Application (NDA) for Luveniq™ (oral voclosporin) for the treatment of non-infectious uveitis involving the intermediate or posterior segments of the eye on June 28, 2010.

12 May 2010

Colorectal cancer screening rates much lower among African Americans: Study

Among African Americans, colorectal cancer is the third most common cause of cancer-related death. With the proper screening, it has a 90 percent cure rate, yet screening rates are much lower among this group than other ethnic groups.

12 May 2010

Medical News

Studies: Trauma centers would be strained by patient load in terrorist attack

MIT featured in U.S. Equity News

Neurimmune Therapeutics honored with ZKB TECHNOPARK Pioneer Award

Vetter signs preferred partnership agreement with Sentry BioPharma Services

Patients who participate in physical therapist-led exercise achieve higher functional mobility: Report

Brookdale Senior Living announces sale of 10,000,000 shares by Fortress Investment Group affiliates

R.I. overhauls Medicaid payments for elderly, disabled; Medicaid delays reported in Kansas

Japanese MHLW approves St. Jude Medical's AnalyST ICD with ST Monitoring device

Angiogenesis inhibitors safe for cancer patients despite hypertension risk: Panel

Tensions escalate between Obama administration, health insurers

St. Jude Medical launches Promote Quadra CRT-D in Europe

CHD mortality rate in Ontario decreased by 35%: Study

Oncos Therapeutics completes € 4 million investment from HealthCap

Sanofi-aventis commences multinational Phase IIIb PALLAS trial of Multaq in permanent AF patients

Study shows high-dose vitamin D therapy may increase risk of fracture in elderly women

Gilead Sciences board authorizes $5 billion common stock repurchase program

NY public hospital system plans to lay off about 500 workers and other state news

LifeCodexx AG develops test using Next Generation Sequencing technologies for prenatal diagnostics

FDA Dermatology and Ophthalmology Drugs Advisory Committee to review Lux Biosciences’ Luveniq NDA

Colorectal cancer screening rates much lower among African Americans: Study

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Latest News